With AJ Bell and Embark confirming they are following Transact down the IPO trail and Nucleus reported to being thinking similarly, Tom Ellis looks at what lies behind the sudden bout of floatation fever sweeping the platform market.
Since Axa sold Elevate to Standard Life in May 2016 and Legal & General parted with Cofunds for a hefty fee in August 2016, little merger and acquisition (M&A) business has taken place in the adviser platform...
Experts react to 2019 Spring Statement
Round-up of key headlines throughout end of December
Trump tops the list
The biggest stories in regulation